IBTK and mantle cell lymphoma: Ongoing trials (NCT04234061 and NCT04484012) evaluating concomitant BTKi and CAR T-cell therapy approaches in R/R MCL will help determine the potential benefit of the BTKi/CAR T-cell combination in R/R MCL.